AtriCure (ATRC) | Stock Overview & Key Data
AtriCure Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $89.18 on November 1, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
AtriCure
ATRC
|
1.43B Small-cap | 3.94% | -0.50% | -8.08% | -31.82% | -28.75% | -8.95% | -40.16% | -61.38% | 94.66% | 127.41% | 234.77% |
|
Intuitive Surgical
ISRG
|
170.06B Large-cap | -0.49% | -1.09% | -13.84% | -25.55% | -25.88% | -19.74% | 24.81% | 40.32% | 476.52% | 974.11% | 3,431.44% |
| 56.10B Large-cap | -2.98% | 1.43% | -9.20% | -7.49% | -5.04% | 8.01% | -28.08% | -20.73% | 15.00% | 123.99% | 212.28% | |
|
Pulse Biosciences
PLSE
|
1.65B Small-cap | 4.35% | 5.58% | 18.74% | 83.44% | 93.58% | 54.53% | 288.68% | 40.54% | 457.67% | 490.07% | 490.07% |
|
Staar Surgical
STAA
|
1.23B Small-cap | -5.31% | -11.54% | 56.91% | 20.42% | 20.21% | 66.10% | -46.07% | -80.50% | 419.60% | 454.10% | 273.29% |
|
Anbio Biotechnology
NNNN
|
1.20B Small-cap | -2.38% | -37.60% | -22.96% | -40.81% | -42.98% | 80.02% | 170.19% | 170.19% | 170.19% | 170.19% | 170.19% |
Ownership & Short Interest
Calculate Your AtriCure Investment Returns
Long-Term Investment Performance Analysis
AtriCure stock price in Jul 2016 was $15.31, A $1,000.00 lump sum investment in AtriCure made 9 years ago would be worth approximately $1,827.56 today, representing a solid return of 82.76%. This translates to an annualized return (CAGR) of 6.27%.
9 Years 10 Months Investment Scenario (Jul 2016 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is ATRC's 52-week high and low?
- In the last 52 weeks, AtriCure reached a high of $43.18 (on January 8, 2026) and a low of $25.36 (on N/A).
- What is the market cap and P/E ratio for ATRC?
- Curious about AtriCure's size and valuation? Its market capitalization stands at 1.43B. When it comes to valuation, the P/E ratio (trailing twelve months) is -117.54, and the forward P/E (looking ahead) is 74.05.
- Does ATRC pay dividends? If so, what's the yield?
- As for dividends, AtriCure isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are AtriCure's main competitors or similar companies to consider before investing?
When looking at AtriCure, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Intuitive Surgical
ISRG170.06B Healthcare Medical Instruments & Supplies -19.74% 24.81% Becton, Dickinson
BDX56.10B Healthcare Medical Instruments & Supplies 8.01% -28.08% Pulse Biosciences
PLSE1.65B Healthcare Medical Instruments & Supplies 54.53% 288.68% Staar Surgical
STAA1.23B Healthcare Medical Instruments & Supplies 66.10% -46.07% Anbio Biotechnology
NNNN1.20B Healthcare Medical Instruments & Supplies 80.02% 170.19% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for AtriCure Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of AtriCure's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -2.40%, the Debt to Equity ratio from the most recent quarter is 15.54, and its Gross Profit Margin stands at 74.97%.
- What is the recent revenue and earnings growth for ATRC?
- Looking at AtriCure's growth, its revenue over the trailing twelve months (TTM) was $535M. Compared to the same quarter last year (YoY), quarterly revenue grew by 13.10%, and quarterly earnings saw a YoY growth of 13.05%.
- How much of ATRC stock is held by insiders and institutions?
- Wondering who owns AtriCure stock? Company insiders (like executives and directors) hold about 3.77% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 99.25%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.